Evaluation of the effect of therapies to support facial disorders on physical, psychological, social and sleep-related aspects

Phase 2

• Conditions: Temporomandibular Joint Dysfunction Syndrome, Pathological conditions, signs and symptoms; C05.500.607.221.897.897

• Registration Number: RBR-7xx7g7
• Lead Sponsor: niversidade Federal do Rio Grande do Norte

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-30
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients with a positive diagnosis for TMD obtained through axis I of the RDC / TMD were included; those who underwent last treatment for TMD with a minimum interval of 3 (three) months; individuals with reports of pain in the orofacial region in the last 3 (three) months; patients aged 18 to 65 years.

Exclusion Criteria

Individuals with impaired cognitive ability who were unable to understand the questions in the questionnaires were excluded; those with a history of head trauma that is related to the etiology of orofacial pain and that can confuse the diagnosis of TMD; those with headaches or intracranial disorders; individuals who have used medications in the past 3 months that interfere with sleep quality such as muscle relaxants, anticonvulsants, antidepressants and anxiolytics; patients using medication to treat TMD or muscle pain; those who had other causes of orofacial pain such as caries, periodontal diseases, neuropathies and fibromyalgia; who had an insurmountable fear of a needle or bleeding disorders (only for the craniopuncture group).

Study & Design

• Study Type: Intervention
• Study Design: Not specified